• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Association between Personality Factors and Metabolic Parameters among Patients with Non-Alcoholic-Fatty Liver Disease and Type 2 Diabetes Mellitus-A Cross-Sectional Study.非酒精性脂肪性肝病和2型糖尿病患者人格因素与代谢参数的关联——一项横断面研究
J Clin Med. 2023 Jul 3;12(13):4468. doi: 10.3390/jcm12134468.
2
[Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].[非酒精性脂肪性肝病增加2型糖尿病发病率:一项基于苏南某乡镇老年人群的队列研究]
Zhonghua Gan Zang Bing Za Zhi. 2021 Sep 20;29(9):867-872. doi: 10.3760/cma.j.cn501113-20200429-00223.
3
Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.疾病认知和自我效能在非酒精性脂肪性肝病患者生活方式改变中的作用。
World J Gastroenterol. 2017 Mar 14;23(10):1881-1890. doi: 10.3748/wjg.v23.i10.1881.
4
Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients.2型糖尿病患者的血清铁蛋白水平、微量白蛋白尿与非酒精性脂肪性肝病
Diabetes Metab Syndr. 2019 May-Jun;13(3):2226-2229. doi: 10.1016/j.dsx.2019.05.030. Epub 2019 May 25.
5
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.非酒精性脂肪性肝病与 2 型糖尿病:韩国糖尿病协会脂肪肝病研究组立场声明。
Diabetes Metab J. 2020 Jun;44(3):382-401. doi: 10.4093/dmj.2020.0010. Epub 2020 May 11.
6
Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Persons with Type 2 Diabetes Mellitus in Ghana: A Study of Prevalence, Severity, and Contributing Factors Using Transient Elastography.加纳2型糖尿病患者的非酒精性脂肪性肝病和肝纤维化:一项使用瞬时弹性成像技术对患病率、严重程度及相关因素的研究
J Clin Med. 2023 May 29;12(11):3741. doi: 10.3390/jcm12113741.
7
[The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].[成人隐匿性自身免疫性糖尿病患者非酒精性脂肪性肝病与代谢综合征的关系]
Zhonghua Yi Xue Za Zhi. 2018 Aug 14;98(30):2398-2402. doi: 10.3760/cma.j.issn.0376-2491.2018.30.006.
8
The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review.健康状况、饮食和生活方式对非酒精性脂肪性肝病的影响:叙述性综述。
Clin Obes. 2022 Aug;12(4):e12525. doi: 10.1111/cob.12525. Epub 2022 Apr 12.
9
Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.非酒精性脂肪性肝病与多囊卵巢综合征女性的胰岛素抵抗及脂质堆积产物相关。
Hum Reprod. 2016 Jun;31(6):1347-53. doi: 10.1093/humrep/dew076. Epub 2016 Apr 12.
10
Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.非酒精性脂肪性肝病治疗在 2 型糖尿病患者中;新的问题出现了。
Curr Vasc Pharmacol. 2020;18(2):172-181. doi: 10.2174/1570161117666190405164313.

引用本文的文献

1
Non-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to Therapy.日常临床实践中的非酒精性脂肪性肝病:从诊断到治疗
Life (Basel). 2025 Feb 25;15(3):363. doi: 10.3390/life15030363.
2
A Cross-Sectional Study Investigating Associations between Personality Traits, Glycemic Control, and BMI in Persons with Diabetes: Lolland-Falster Health Study, Denmark.丹麦洛兰-法斯特健康研究:一项横断面研究调查糖尿病患者的人格特质、血糖控制和 BMI 之间的关联。
Int J Environ Res Public Health. 2024 Sep 18;21(9):1231. doi: 10.3390/ijerph21091231.
3
Salvia miltiorrhiza bge. f. alba ameliorates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease via the STING pathway.白花丹参通过STING通路改善2型糖尿病相关的非酒精性脂肪性肝病。
Am J Transl Res. 2024 Aug 15;16(8):3678-3689. doi: 10.62347/XUNO9933. eCollection 2024.
4
Self-management behaviours in adults with non-alcoholic fatty liver disease: a cross-sectional survey from China.非酒精性脂肪性肝病成人的自我管理行为:来自中国的横断面调查。
BMJ Open. 2024 Feb 22;14(2):e078333. doi: 10.1136/bmjopen-2023-078333.

本文引用的文献

1
The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.非酒精性脂肪肝疾病和肝纤维化对慢性肾脏病患者不良临床结局和死亡率的影响:利用英国生物库的前瞻性队列研究。
BMC Med. 2023 May 18;21(1):185. doi: 10.1186/s12916-023-02891-x.
2
What's New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病(NAFLD)治疗的新进展
J Clin Med. 2023 Feb 26;12(5):1852. doi: 10.3390/jcm12051852.
3
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.美国肝病研究学会非酒精性脂肪性肝病临床评估与管理实践指南
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
4
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.2. 糖尿病的分类和诊断:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
5
Dietary Intake and Nutritional Status in Young and Middle-Aged Adults according to the Meal Frequency from the Korea National Health and Nutritional Survey.根据韩国国民健康与营养调查的用餐频率,分析中青年成年人的饮食摄入量和营养状况。
Korean J Fam Med. 2022 Sep;43(5):319-326. doi: 10.4082/kjfm.21.0149. Epub 2022 Sep 20.
6
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.非肥胖性非酒精性脂肪性肝病(NAFLD)患者与非非肥胖性 NAFLD 患者代谢功能障碍负担的比较:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1750-1760.e12. doi: 10.1016/j.cgh.2022.06.029. Epub 2022 Jul 19.
7
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis.1 型和 2 型糖尿病患者肝硬度升高的患病率:系统评价和荟萃分析。
Diabetes Res Clin Pract. 2022 Aug;190:109981. doi: 10.1016/j.diabres.2022.109981. Epub 2022 Jul 5.
8
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
9
SELF-CARE AND QUALITY OF LIFE PEOPLE WITH TYPE 2 DIABETES DURING THE COVID-19: CROSS-SECTIONAL STUDY.2型糖尿病患者在新冠疫情期间的自我护理与生活质量:横断面研究
J Diabetes Metab Disord. 2022 May 26;21(1):785-790. doi: 10.1007/s40200-022-01055-7. eCollection 2022 Jun.
10
Affective Temperament and Glycemic Control - The Psychological Aspect of Obesity and Diabetes Mellitus.情感气质与血糖控制——肥胖症和糖尿病的心理层面
Diabetes Metab Syndr Obes. 2021 Dec 30;14:4981-4991. doi: 10.2147/DMSO.S342185. eCollection 2021.

非酒精性脂肪性肝病和2型糖尿病患者人格因素与代谢参数的关联——一项横断面研究

The Association between Personality Factors and Metabolic Parameters among Patients with Non-Alcoholic-Fatty Liver Disease and Type 2 Diabetes Mellitus-A Cross-Sectional Study.

作者信息

Kosmalski Marcin, Frankowski Rafał, Różycka-Kosmalska Monika, Sipowicz Kasper, Pietras Tadeusz, Mokros Łukasz

机构信息

Department of Clinical Pharmacology, Medical University of Lodz, 90-153 Lodz, Poland.

Students' Research Club, Department of Clinical Pharmacology, Medical University of Lodz, 90-153 Lodz, Poland.

出版信息

J Clin Med. 2023 Jul 3;12(13):4468. doi: 10.3390/jcm12134468.

DOI:10.3390/jcm12134468
PMID:37445503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10342671/
Abstract

BACKGROUND

The increasing prevalence of type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) states a serious problem for public health. The introduction of effective methods of treatment and prevention is crucial to avoid complications of these diseases. Among them, we can specify psychological factors that affect everyday life and determine the patient's attitude towards therapy, and what follows, their compliance in treatment. The literature indicates these connections in various ways; in our study, we extend this view to include a broader perspective of human personality.

OBJECTIVE

We decided to investigate the associations between personality factors and metabolic parameters in patients with NAFLD and T2DM in order to better understand the patient's approach to the treatment of a chronic disease, such as those mentioned, and to establish the basis for further research implementing psychological interventions in the treatment of NAFLD and T2DM.

METHODS

One hundred participants with NAFLD and T2DM underwent blood tests and anthropometric measures. Each of them was asked to complete five questionnaires evaluating their personality properties.

RESULTS

We revealed that a rise in body mass index is related to a fall in the emotional intelligence factor of utilizing emotions, and a rise in emotional perception. The decrease in task-oriented coping style and a rise in emotion-oriented coping style are associated with a waist-hip ratio increase. The increase in fasting plasma glucose is predicted by a decrease in task-oriented coping style score. A fall in social diversion coping style score is associated with a high-density lipoprotein increase; in turn, a triglycerides increase is connected with a decline in rhythmicity score.

CONCLUSIONS

The personality factors are in relationship in the management of NAFLD and T2DM. They affect a patient's approach to treatment, which is very important, because we know lifestyle and dietary interventions are an important part of the treatment of these diseases. The compliance manifests by lifestyle modifications, taking medications regularly, measuring blood glucose, and inspection visits in outpatients' clinics are a large part of a diabetic's life. Future studies introducing psychological intervention to improve, e.g., coping styles or rhythmicity are needed to implement new methods of patient management.

摘要

背景

2型糖尿病(T2DM)和非酒精性脂肪性肝病(NAFLD)的患病率不断上升,给公共卫生带来了严重问题。引入有效的治疗和预防方法对于避免这些疾病的并发症至关重要。其中,我们可以明确影响日常生活的心理因素,并确定患者对治疗的态度,以及随之而来的治疗依从性。文献以各种方式表明了这些联系;在我们的研究中,我们将这一观点扩展到包括更广泛的人格视角。

目的

我们决定研究NAFLD和T2DM患者人格因素与代谢参数之间的关联,以便更好地理解患者对上述慢性病治疗的态度,并为在NAFLD和T2DM治疗中实施心理干预的进一步研究奠定基础。

方法

100名NAFLD和T2DM患者接受了血液检查和人体测量。他们每人被要求完成五份评估其人格特质的问卷。

结果

我们发现体重指数的升高与利用情绪的情商因素下降以及情绪感知的升高有关。任务导向型应对方式的减少和情绪导向型应对方式的增加与腰臀比的增加有关。空腹血糖的升高可通过任务导向型应对方式得分的降低来预测。社交转移应对方式得分的下降与高密度脂蛋白的升高有关;反过来,甘油三酯的升高与节律性得分的下降有关。

结论

人格因素在NAFLD和T2DM的管理中存在关联。它们影响患者的治疗态度,这非常重要,因为我们知道生活方式和饮食干预是这些疾病治疗的重要组成部分。通过改变生活方式、定期服药、测量血糖以及在门诊就诊来表现的依从性是糖尿病患者生活的很大一部分。未来需要开展引入心理干预以改善应对方式或节律性等的研究,以实施新的患者管理方法。